about
Mozambique's journey toward accreditation of the National Tuberculosis Reference Laboratory.Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosisIsoniazid Resistance in Mycobacterium tuberculosis Is a Heterogeneous Phenotype Composed of Overlapping MIC Distributions with Different Underlying Resistance MechanismsApp-based symptoms screening with Xpert MTB/RIF Ultra assay used for active tuberculosis detection in migrants at point of arrivals in Italy: The E-DETECT TB intervention analysisCelebrating TB day at the time of COVID-19Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in PakistanSame meat, different gravy: ignore the new names of mycobacteriaWhole-Genome Sequences of Two NDM-1-Producing Pseudomonas aeruginosa Strains Isolated in a Clinical Setting in Albania in 2018Treating Primary Arthroprosthesis Infection Caused by Mycobacterium abscessus subsp. abscessusPrevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional dataValidation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study
P50
Q41103369-E32CC60A-1E2B-4CED-A6B1-25D6E62B1EF6Q57922209-AA19AA27-B01E-4E8D-950C-C62C9DBD6114Q90212796-CB01328F-834F-494F-A31C-B2AD115DAE74Q91509371-CEADBBA2-57B9-471B-98E8-8F7A8082B310Q91520274-5E639042-C08E-4D27-9027-B45298B2CB72Q91526132-2D879851-A4E9-41E7-A527-4F33D6FB9E23Q91808953-90CBAC68-ECC0-474B-BCCB-6D5D00181062Q92379844-B12D2EBB-7199-4755-83CF-F30E1BBC682FQ92592756-67EAD07F-C58B-42E8-948A-36C4A24578D5Q92802220-1FBBA454-1D44-4ECC-A0C8-C0FD9EE94696Q92859152-B218977C-7BB1-4B89-877B-09D68FE6A68C
P50
description
researcher
@en
name
Daniela M Cirillo
@en
type
label
Daniela M Cirillo
@en
prefLabel
Daniela M Cirillo
@en
P31
P496
0000-0001-6415-1535